Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Parmax Pharma Ltd held an EGM on May 27, 2025 with e-voting conducted from May 24-26, 2026. Five resolutions were voted upon. Two ordinary resolutions passed: appointment of Mr. Pradeep Ramniklal Gosalia as Non-Executive Director (57.04% votes for) and Ms. Salma Badruzza Thobhani as Non-Executive Director (69.95% votes for). Two special resolutions failed to pass: appointment of Mr. Ashish Atmaram Shah and Ms. Anjana Paresh Shah as Independent Directors both received 69.95% votes for, falling short of the 75% threshold required for special resolutions. One special resolution passed unanimously: re-appointment of Mr. Umang Alkesh Gosalia as Managing Director with 100% votes for and zero against. Notably, 302,714 invalid votes were recorded for Item 1 (12.91%).
The rejection of two independent director appointments signals potential governance concerns or shareholder disagreement with those nominees. The unanimous re-appointment of the Managing Director shows strong confidence in current leadership. High invalid voting on Item 1 may indicate procedural or technical issues.